TNF and hepatocellular carcinoma: Based on the numbers and corrected p-values of these DEGs, which were adjusted by the Bonferroni correction, the DEGs in PD-treated HepG2 cells were significantly enriched in the hepatocellular carcinoma (HCC) set, TNF signaling pathway, Hippo signaling pathway, steroid biosynthesis pathway, etc. (Figure 4B).